Addex Therapeutics Stock Last Dividend Paid
| ADXN Stock | CHF 0.06 0 6.01% |
Addex Therapeutics fundamentals help investors to digest information that contributes to Addex Therapeutics' financial success or failures. It also enables traders to predict the movement of Addex Stock. The fundamental analysis module provides a way to measure Addex Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Addex Therapeutics stock.
Addex |
Addex Therapeutics Company Last Dividend Paid Analysis
Addex Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Addex Therapeutics has a Last Dividend Paid of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Last Dividend Paid (which currently averages 0.0) industry. This indicator is about the same for all Switzerland stocks average (which is currently at 0.0).
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Addex Fundamentals
| Return On Equity | -2.03 | |||
| Return On Asset | -0.88 | |||
| Operating Margin | (17.07) % | |||
| Current Valuation | 2.92 M | |||
| Shares Outstanding | 115.35 M | |||
| Shares Owned By Insiders | 8.96 % | |||
| Shares Owned By Institutions | 9.31 % | |||
| Price To Earning | 39.53 X | |||
| Price To Book | 1.62 X | |||
| Price To Sales | 9.82 X | |||
| Revenue | 2.92 M | |||
| Gross Profit | (9.69 M) | |||
| EBITDA | (14.94 M) | |||
| Net Income | (15.35 M) | |||
| Cash And Equivalents | 20.48 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 194.32 K | |||
| Current Ratio | 18.06 X | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (14.71 M) | |||
| Earnings Per Share | (0.53) X | |||
| Target Price | 0.16 | |||
| Number Of Employees | 26 | |||
| Beta | 1.88 | |||
| Market Capitalization | 28.26 M | |||
| Total Asset | 22.54 M | |||
| Z Score | 87.0 | |||
| Net Asset | 22.54 M |
About Addex Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Addex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Addex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Addex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Addex Stock Analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.